These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 36894940)

  • 1. Deep phenotyping towards precision psychiatry of first-episode depression - the Brain Drugs-Depression cohort.
    Jensen KHR; Dam VH; Ganz M; Fisher PM; Ip CT; Sankar A; Marstrand-Joergensen MR; Ozenne B; Osler M; Penninx BWJH; Pinborg LH; Frokjaer VG; Knudsen GM; Jørgensen MB
    BMC Psychiatry; 2023 Mar; 23(1):151. PubMed ID: 36894940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
    Cerbo AD
    Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial Protocol.
    Köhler-Forsberg K; Jorgensen A; Dam VH; Stenbæk DS; Fisher PM; Ip CT; Ganz M; Poulsen HE; Giraldi A; Ozenne B; Jørgensen MB; Knudsen GM; Frokjaer VG
    Front Psychiatry; 2020; 11():641. PubMed ID: 32792991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression.
    Poulin JM; Bigford GE; Lanctôt KL; Giacobbe P; Schaffer A; Sinyor M; Rabin JS; Masellis M; Singnurkar A; Pople CB; Lipsman N; Husain MI; Rosenblat JD; Cao X; MacIntosh BJ; Nestor SM
    Trials; 2024 Jul; 25(1):441. PubMed ID: 38956594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irritability and Its Clinical Utility in Major Depressive Disorder: Prediction of Individual-Level Acute-Phase Outcomes Using Early Changes in Irritability and Depression Severity.
    Jha MK; Minhajuddin A; South C; Rush AJ; Trivedi MH
    Am J Psychiatry; 2019 May; 176(5):358-366. PubMed ID: 30922100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report.
    Rush AJ; Wisniewski SR; Zisook S; Fava M; Sung SC; Haley CL; Chan HN; Gilmer WS; Warden D; Nierenberg AA; Balasubramani GK; Gaynes BN; Trivedi MH; Hollon SD
    Psychol Med; 2012 Jun; 42(6):1131-49. PubMed ID: 22008447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation.
    Trivedi MH; Rush AJ; Ibrahim HM; Carmody TJ; Biggs MM; Suppes T; Crismon ML; Shores-Wilson K; Toprac MG; Dennehy EB; Witte B; Kashner TM
    Psychol Med; 2004 Jan; 34(1):73-82. PubMed ID: 14971628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
    Sung SC; Haley CL; Wisniewski SR; Fava M; Nierenberg AA; Warden D; Morris DW; Kurian BT; Trivedi MH; Rush AJ;
    J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.
    Davis AK; Barrett FS; May DG; Cosimano MP; Sepeda ND; Johnson MW; Finan PH; Griffiths RR
    JAMA Psychiatry; 2021 May; 78(5):481-489. PubMed ID: 33146667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Rajpurkar P; Yang J; Dass N; Vale V; Keller AS; Irvin J; Taylor Z; Basu S; Ng A; Williams LM
    JAMA Netw Open; 2020 Jun; 3(6):e206653. PubMed ID: 32568399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimensions of anxiety in Major depressive disorder and their use in predicting antidepressant treatment outcome: an iSPOT-D report.
    Braund TA; Palmer DM; Williams LM; Harris AWF
    Psychol Med; 2020 Apr; 50(6):1032-1042. PubMed ID: 31023398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D report.
    Gilmer WS; Gollan JK; Wisniewski SR; Howland RH; Trivedi MH; Miyahara S; Fleck J; Thase ME; Alpert JE; Nierenberg AA; Warden D; Fava M; Rush AJ
    J Clin Psychiatry; 2008 Aug; 69(8):1246-56. PubMed ID: 18681756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
    Trivedi MH; Rush AJ; Wisniewski SR; Nierenberg AA; Warden D; Ritz L; Norquist G; Howland RH; Lebowitz B; McGrath PJ; Shores-Wilson K; Biggs MM; Balasubramani GK; Fava M;
    Am J Psychiatry; 2006 Jan; 163(1):28-40. PubMed ID: 16390886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Neurostimulation of the Brain in Depression Trial: Protocol for a Randomized Controlled Trial of Transcranial Direct Current Stimulation in Treatment-Resistant Depression.
    Suleman R; Tucker BV; Dursun SM; Demas ML
    JMIR Res Protoc; 2021 Mar; 10(3):e22805. PubMed ID: 33729165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The remission from depression questionnaire as an outcome measure in the treatment of depression.
    Zimmerman M; Martinez JH; Attiullah N; Friedman M; Toba C; Boerescu DA
    Depress Anxiety; 2014 Jun; 31(6):533-8. PubMed ID: 24115164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mindfulness-based cognitive therapy (MBCT) versus the health-enhancement program (HEP) for adults with treatment-resistant depression: a randomized control trial study protocol.
    Eisendrath SJ; Gillung EP; Delucchi KL; Chartier M; Mathalon DH; Sullivan JC; Segal ZV; Feldman MD
    BMC Complement Altern Med; 2014 Mar; 14():95. PubMed ID: 24612825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.
    Williams LM; Rush AJ; Koslow SH; Wisniewski SR; Cooper NJ; Nemeroff CB; Schatzberg AF; Gordon E
    Trials; 2011 Jan; 12():4. PubMed ID: 21208417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy outcomes in the MDD-1 India study: First episode major depressive disorder outcomes in antidepressant-treated real-world patients in India.
    Andrade C; De Sousa A; Shah N
    J Psychopharmacol; 2020 Oct; 34(10):1098-1104. PubMed ID: 32684093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.